Hematologic Malignancies
Showing 51 - 75 of 136
Cancer, Hematologic Malignancies Trial in Houston (TAPA-pulsed DC vaccine)
Withdrawn
- Cancer
- Hematologic Malignancies
- TAPA-pulsed DC vaccine
-
Houston, TexasMD Anderson Cancer Center
Oct 10, 2019
Hematologic Malignancies Trial in Maywood (StemEx)
Completed
- Hematologic Malignancies
- StemEx
-
Maywood, IllinoisLoyola University Medical Center
Aug 19, 2019
Advanced Solid Malignancies, Hematologic Malignancies Trial in Fort Myers, Oklahoma City, Nashville (MLN0128, paclitaxel,
Completed
- Advanced Solid Malignancies
- Hematologic Malignancies
- MLN0128
- +2 more
-
Fort Myers, Florida
- +2 more
Jun 28, 2019
Hematologic Malignancies Trial in Durham (Home Care)
Completed
- Hematologic Malignancies
- Home Care
-
Durham, North CarolinaDuke University Medical Center
Jul 15, 2019
Solid Tumor, Hematologic Malignancies Trial in United States (BGJ398)
Terminated
- Solid Tumor
- Hematologic Malignancies
-
Birmingham, Alabama
- +55 more
May 28, 2019
Cancer Patients' Performance Status Assessed Using
Completed
- Malignant Solid Tumor
- Hematologic Malignancies
- Biometric Devices
- Physical Performance Testing
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center
Feb 21, 2019
Exercise Capacity and Physical Activity Levels in Newly
Completed
- Hematologic Malignancies
-
Yenimahalle, TurkeyGazi University Faculty of Health Sciences Department of Physica
Feb 13, 2019
Hematologic Malignancies Trial in Bergamo, Bolzano, Monza (in vitro expanded Cytokine Induced Killer (CIK) cells)
Completed
- Hematologic Malignancies
- in vitro expanded Cytokine Induced Killer (CIK) cells
-
Bergamo, Italy
- +2 more
Jan 17, 2019
Hematologic Malignancies Trial in Italy (UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELLS (UC-MSC))
Unknown status
- Hematologic Malignancies
- UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELLS (UC-MSC)
-
Bergamo, Italy
- +7 more
Jan 17, 2019
Hematologic Malignancies Trial in Houston (Tezacitabine (FMdC))
Completed
- Hematologic Malignancies
- Tezacitabine (FMdC)
-
Houston, TexasUT MD Anderson Cancer Center
Oct 31, 2018
Hematologic Malignancies Trial in Duarte, Boston (Biological: ProHema-CB)
Terminated
- Hematologic Malignancies
- Biological: ProHema-CB
-
Duarte, California
- +1 more
Feb 28, 2018
Hematologic Malignancies Trial in Marseille (Monalizumab)
Unknown status
- Hematologic Malignancies
-
Marseille, Bouches Du Rhônes, FranceInstitut Paoli Calmettes
Sep 18, 2018
Cancer, Hematologic Malignancies Trial (TAPA-pulsed DC vaccine)
Withdrawn
- Cancer
- Hematologic Malignancies
- TAPA-pulsed DC vaccine
- (no location specified)
Aug 24, 2018
Chronic Myelogenous Leukemia, Hematologic Malignancies Trial in United States (Ponatinib)
Completed
- Chronic Myelogenous Leukemia
- Hematologic Malignancies
-
San Francisco, California
- +4 more
May 15, 2018
Hematologic Malignancies Trial in Lebanon (Pegfilgrastim)
Terminated
- Hematologic Malignancies
-
Lebanon, New HampshireDartmouth-Hitchcock Medical Center
Mar 22, 2018
Physical Fitness in Cancer Cardiopulmonary Exercise Testing and
Completed
- Malignant Solid Tumour
- +2 more
- Physical performance testing and patient-generated health data
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center
Mar 21, 2018
Pre-transplant Comorbidities and Post-transplant Toxicities and
Completed
- Hematologic Malignancies
- Other Diagnoses, Comorbidities, and Complications
-
Seattle, WashingtonFred Hutchinson Cancer Research Center
Jan 9, 2018
Hematologic Malignancies Trial in Minneapolis (biological, drug, radiation)
Withdrawn
- Hematologic Malignancies
- T Regulatory cells
- +3 more
-
Minneapolis, MinnesotaUniversity of Minnesota Masonic Cancer Center
Nov 29, 2017
Cancer, Hematologic Malignancies, Leukemia Trial in Stony Brook, Cleveland, Houston (Arm 1- Dose Escalation, Arm 2- Dose
Completed
- Cancer
- +3 more
- Arm 1- Dose Escalation
- Arm 2- Dose Expansion
-
Stony Brook, New York
- +2 more
Nov 1, 2017
Hematologic Malignancies Trial in Seoul (Matching on the basis of molecular analysis, Matching on the basis of physician's
Unknown status
- Hematologic Malignancies
- Matching on the basis of molecular analysis
- Matching on the basis of physician's choice
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 24, 2017
Hematologic Malignancies Trial in Atlanta (Granulocyte Colony Stimulating Factor)
Terminated
- Hematologic Malignancies
- Granulocyte Colony Stimulating Factor
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta/Emory University
Aug 10, 2017
T Cell and Natural Killer Cell in Relation to Viral Infections
Completed
- Hematologic Malignancies
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jul 14, 2017
Hematologic Malignancies, Multiple Myeloma Trial in Worldwide (Bz (Bortezomib), Len (lenalidomide))
Completed
- Hematologic Malignancies
- Multiple Myeloma
- Bz (Bortezomib)
- Len (lenalidomide)
-
Würzburg,, Germany
- +9 more
Jul 5, 2017